Eyenovia, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EYEN research report →
Companywww.eyenovia.com
Eyenovia, Inc. , a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system.
- CEO
- Michael M. Rowe
- IPO
- 2018
- Employees
- 13
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $38.59M
- P/E
- -1.22
- P/S
- 18.09
- P/B
- 0.69
- EV/EBITDA
- -1.83
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.68%
- Op Margin
- -2012.57%
- Net Margin
- -3163.01%
- ROE
- -63.54%
- ROIC
- -31.07%
Growth & Income
- Revenue
- $813.46M · 1418650.87%
- Net Income
- $-46,999,218,000 · -94241.02%
- EPS
- $0.00 · 100.00%
- Op Income
- $-46,721,061
- FCF YoY
- -48674.69%
Performance & Tape
- 52W High
- $124.80
- 52W Low
- $0.85
- 50D MA
- $4.53
- 200D MA
- $9.74
- Beta
- 1.00
- Avg Volume
- 4.65M
Get TickerSpark's AI analysis on EYEN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 21, 25 | Avenue Capital Management II, L.P. | other | 5,952,381 |
| Jan 31, 25 | Avenue Capital Management II, L.P. | other | 0 |
| Nov 22, 22 | Avenue Capital Management II, L.P. | other | 2,327,747 |
| Apr 21, 25 | Strahlman Ellen R | other | 3,000 |
| Apr 21, 25 | Palanki Ram | other | 3,000 |
| Apr 21, 25 | MATHER CHARLES E IV | other | 8,000 |
| Apr 21, 25 | JACOBSON RACHEL | other | 3,000 |
| Apr 21, 25 | Ianchulev Tsontcho | other | 5,000 |
| Apr 21, 25 | GELTZEILER MICHAEL S | other | 5,000 |
| Apr 21, 25 | Strahlman Ellen R | other | 3,000 |
Our EYEN Coverage
We haven't published any research on EYEN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EYEN Report →